USFDA gives establishment inspection report to Natco Pharma
DSIJ Intelligence / 20 Jul 2017
U.S. Food and Drug Administration (FDA) for the inspection conducted at its drug formulations facility at Kothur Unit, Telangana, India
Establishment Inspection Report (EIR) has been received by Natco Pharma from the U.S. Food and Drug Administration (FDA) for the inspection conducted at its drug formulations facility at Kothur Unit, Telangana, India, during the period January 16 to January 24, 2017, said the company in a BSE filing on Thursday.
The company's Kothur formulation facility predominantly caters to regulated international markets, including USA.
At Rs 1008.95, Natco Pharma was trading up by Rs 8.75 or 0.88% as of 1040 hours on Thursday, on the BSE.
The stock has attracted traded volume of 2,27,293 shares and traded value of Rs 2,302.02 lakh on the NSE. The company has hit its 52-week high of Rs 1090 on June 9, 2017 and 52-week low of Rs 500 on November 9, 2016.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.